Takayuki Sato

A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy

T. Shinohara, Y. Miyake, Yutaka Y. Yasui, 2021, Nature Communications.

Feeder-free differentiation and expansion for T cells from induced pluripotent stem cells

T. Shinohara, Y. Miyake, Yutaka Y. Yasui, 2021 .

Human iPSC-derived CD4+ Treg-like cells engineered with chimeric antigen receptors control GvHD in a xenograft model.

S. Iriguchi, Takayuki Sato, S. Kaneko, 2024, Cell stem cell.